The Summer School is organised by the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Department of Health Economics at the Austrian Public Health Institute (Gesundheit Österreich GmbH, GÖG) in Vienna, Austria in collaboration with WHO Regional Office for Europe
The WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies was nominated in summer 2010 and re-designated as a centre for expertise in summer 2014 by the World Health Organization (WHO). The Centre has a dedicated team of academics working closely with the WHO, at international and European levels. It facilitates the development of a public health approach in pharmaceutical pricing and reimbursement policies through research, exchange and dissemination of the evidence base of best-practice models and knowledge transfer. The long-standing expertise at the WHO Collaborating Centre has been built upon numerous national and international projects, initiatives and networks.
A special initiative within this context is the Pharmaceutical Pricing and Reimbursement Information (PPRI) network. PPRI was originally an EU-funded project (2005 – 2007) which aimed to improve information and knowledge on pharmaceutical systems in Europe since no such initiative existed at that time. In course of this project, the PPRI network was established, currently with 46 member countries. Thereby a set of pharmaceutical indicators with real data from 28 PPRI countries, as well as more than 20 country reports and brief overviews on the pharmaceutical systems (country information) were produced. Since 2008, PPRI has continued a Member States driven initiative because policy makers represented in the PPRI network expressed their strong interest to continue the cooperation.
Eligible institutions for PPRI are competent authorities for pharmaceutical pricing and reimbursement. As of 2016, the PPRI network comprises around 80 institutions from 46 countries (all 28 EU Member States, in addition to Armenia, Albania, Belarus, Canada, Macedonia, Moldova, Norway, Iceland, Israel, Kazakhstan, Kyrgyzstan, Russia, Switzerland, Serbia, South Africa, South Korea, Turkey, and Ukraine), the European Commission Services and Agency, OECD, WHO and the World Bank. For further information see http://whocc.goeg.at/Networks/ListOfMembers and http://whocc.goeg.at/Literaturliste/Dokumente/Articles/Vogler_PPRI_HealthPolicyTechnology_2014.pdf
In October 2015, the WHO Collaborating Centre organised the 3rd international PPRI Conference ‘Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis’ in Vienna. For further information, including presentations, abstract and country poster book, Conference supplement, see Conference website: http://whocc.goeg.at/Conference2015
The WHO Collaborating Centre disposes of in-depth expertise in medicine-price surveys, analyses and comparisons. It maintains the Pharmaceutical Price Information (PPI) service (http://whocc.goeg.at/Topics/PharmaPriceInformation) which offers independent, reliable and up-to-date medicine-price information at ex-factory, wholesale (pharmacy purchasing price) and pharmacy retail price levels to 30 European countries.
The WHO Collaborating Centre has been regularly offering trainings and courses for staff of competent authorities.